Maharana Prafulla K, Raghuwanshi Sapna, Chauhan Ashish K, Rai Vaishali G, Pattebahadur Rajesh
Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Department of Community Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Middle East Afr J Ophthalmol. 2017 Oct-Dec;24(4):202-206. doi: 10.4103/meajo.MEAJO_165_15.
To compare the efficacy of carboxymethylcellulose 0.5% (CMC), hydroxypropyl-guar containing polyethylene glycol 400/propylene glycol (PEG/PG), and hydroxypropyl methylcellulose 0.3% (HPMC) as tear substitutes in patients with dry eye.
A retrospective evaluation of cases presenting with symptoms of dry eye from July 2014 to June 2015 was done. Patients with Ocular Surface Disease Index (OSDI) scoring >12 were included in the study. Parameters such as age, gender, Schirmer test (ST), and tear film breakup time (TBUT) were recorded on day 0, week 1, and week 4. For analysis, cases were divided into three groups; Group 1 - CMC, Group 2 - PEG/PG, and Group 3 - HPMC.
Overall, 120 patients were included in the study. Demographic data and baseline characteristics were comparable among the groups. Group 2 had significant improvement in percentage change in OSDI (weeks 0-1, 0-4, and 1-4, = 0.00), TBUT (weeks 0-1, = 0.01; 0-4, = 0.006; and 1-4, = 0.007), and in ST (weeks 0-1, = 0.02; 0-4, = 0.002; and 1-4, = 0.008) compared to Group 1 at all follow-ups. Group 3 had improvements similar to Group 2, but it was not at all follow-ups (improvement in percentage change OSDI [weeks 0-1, 0-4, and 1-4, = 0.00], TBUT [weeks 0-1, = 0.10; 0-4, = 0.03; and 1-4, = 0.04], and in ST [weeks 0-1, = 0.007; 0-4, = 0.03; and 1-4, = 0.12]). No significant difference was found between Groups 2 and 3.
Hydroxypropyl-guar containing PEG/PG and HPMC as tear substitutes are better than CMC. While HPMC was comparable to PEG/PG in subjective improvement, the objective improvement was not consistent.
比较0.5%羧甲基纤维素(CMC)、含聚乙二醇400/丙二醇的羟丙基瓜尔胶(PEG/PG)和0.3%羟丙基甲基纤维素(HPMC)作为泪液替代物治疗干眼患者的疗效。
对2014年7月至2015年6月出现干眼症状的病例进行回顾性评估。眼表疾病指数(OSDI)评分>12的患者纳入研究。在第0天、第1周和第4周记录年龄、性别、泪液分泌试验(ST)和泪膜破裂时间(TBUT)等参数。为进行分析,将病例分为三组;第1组 - CMC,第2组 - PEG/PG,第3组 - HPMC。
总体而言,120例患者纳入研究。各组间人口统计学数据和基线特征具有可比性。与第1组相比,第2组在所有随访中OSDI百分比变化(第0 - 1周、0 - 4周和1 - 4周,P = 0.00)、TBUT(第0 - 1周,P = 0.01;0 - 4周,P = 0.006;1 - 4周,P = 0.007)和ST(第0 - 1周,P = 0.02;0 - 4周,P = 0.002;1 - 4周,P = 0.008)方面有显著改善。第3组的改善与第2组相似,但并非在所有随访中(OSDI百分比变化改善[第0 - 1周、0 - 4周和1 - 4周,P = 0.00],TBUT[第0 - 1周,P = 0.10;0 - 4周,P = 0.03;1 - 4周,P = 0.04],ST[第0 - 1周,P = 0.007;0 - 4周,P = 0.03;1 - 4周,P = 0.12])。第2组和第3组之间未发现显著差异。
含PEG/PG的羟丙基瓜尔胶和HPMC作为泪液替代物优于CMC。虽然HPMC在主观改善方面与PEG/PG相当,但客观改善并不一致。